Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi UK Government Bond 0-5Y UCITS ETF Dist
GIL5 · LU1439943090 · class UCITS ETF Dist · GBP · domicile Luxembourg
Bonds · Government · 0-5 years · EuropeSFDR art. 6
Index tracked: FTSE Actuaries UK Conventional Gilts Up To 5 Years index
- TER
- 0.05%+ trans. 0.05%
- Fund size
- 517 m EUR
- Tracking difference
- −0.04%3-year avg
- 🇮🇹 tax rate
- 12.95%white list 96.64%
- Replication
- Physical
- Income
- Distributingannual
- Duration
- 2.32 yrsshort (≤3 years)
Launch 12 Jul 2016 · costs from the KID as of 2 Sept 2026 · 19 securities held
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 7 Aug 2026
The Fund is an index-tracking UCITS passively managed. The investment objective of the Fund is to reflect the performance of the FTSE Actuaries UK Conventional Gilts Up To 5 Years index (the Benchmark Index") denominated in GBP and representative of UK government bonds ("Gilts") with remaining maturities up to 5 years, while minimizing the volatility of the difference between the return of the Fund and the return of the Benchmark Index (the "Tracking Error"). The anticipated level of Tracking Error in normal market conditions is indicated in the…
Performance since series start (in euro) — base 100
11 Jul 2016 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +3.8% |
| 3 years | +12.9% |
| 5 years | +7.6% |
| 10 years | +6.4% |
| Since series start | +8.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 2.90% | 2.58% | 2.87% |
| Max drawdown | −2.94% | −2.94% | −9.66% |
| Sharpe | -0.69 | -0.35 | -0.90 |
| Sortino | -0.77 | -0.41 | -1.11 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · GIL5 · LU14399430901
RebalixGIL5 · LU1439943090 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +5.12% | +5.14% | −0.02% |
| 2024 | +2.50% | +2.54% | −0.04% |
| 2023 | +4.07% | +4.13% | −0.07% |
| 2022 | −4.55% | −4.50% | −0.05% |
| 2021 | −1.71% | −1.63% | −0.07% |
Fixed income — as declared by the issuer
Factsheet
Distributions · per share, in GBP
Frequency: annual · last 12 months: 0.41 GBP (2.32% of NAV) · last ex-date 9 Dec 2025
| Year | Payments | Total (GBP) | Dividend yield |
|---|---|---|---|
| 2025 | 1 | 0.41 | +2.41% |
| 2024 | 1 | 0.33 | +1.95% |
| 2023 | 1 | 0.23 | +1.39% |
| 2022 | 2 | 0.23 | +1.31% |
| 2021 | 2 | 0.28 | +1.55% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 19 securities · top-10 weight = 59.0%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU1439943090
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1439943090
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · GIL5 · LU14399430902